Awareness, Knowledge and Attitudes Towards Cervical Cancer Amongst HIV-Positive Women Receiving Care in a Tertiary Hospital in Nigeria
Overview
Oncology
Authors
Affiliations
The incidence of cervical cancer (CC) in the sub-Saharan Africa region, where Nigeria is located, is amongst the highest in the world; it is estimated that 70,722 new cases of invasive cervical cancer occur annually in sub-Saharan Africa. Immunosuppression, especially due to human immunodeficiency virus (HIV) infection, is a predisposing factor for persistent infection with high-risk human papilloma virus (HR-HPV) and the development of squamous intraepithelial lesions. Four hundred and fifty women who attended the HIV clinic at the Nnamdi Azikiwe University Teaching Hospital, Nnewi, and who consented to participate in the study were randomly selected. They were given self-administered questionnaires which sought to determine their awareness and knowledge of cervical cancer and attitudes towards cervical cancer screening and prevention. The media 23% (n = 103) was the most common source of information amongst respondents who had heard about cervical cancer. For all the women surveyed, the average percentage knowledge was 9.95%. Having attitude scores greater than or equal to the mean attitude score of 55.16% was regarded as having a positive attitude while a score lower than that was regarded as negative attitude. About 43.5% (n = 195) respondents had a positive attitude towards cervical cancer screening and prevention. Cervical cancer awareness and knowledge amongst women attending the HIV clinic in the Nnamdi Azikiwe University Teaching Hospital, Nnewi, were very poor. Their attitude towards cervical cancer screening practices and prevention was also very poor.
Bogale A, Ali J, Sherif Z Cancer Control. 2024; 31:10732748241284943.
PMID: 39279129 PMC: 11403674. DOI: 10.1177/10732748241284943.
Olakunde B, Itanyi I, Olawepo J, Liu L, Bembir C, Idemili-Aronu N Implement Sci. 2024; 19(1):25.
PMID: 38468266 PMC: 10926605. DOI: 10.1186/s13012-024-01349-9.
Tesfaye E, Kumbi B, Mandefro B, Hemba Y, Prajapati K, Singh S Sci Rep. 2024; 14(1):4053.
PMID: 38374354 PMC: 10876560. DOI: 10.1038/s41598-024-54754-x.
Arechkik A, Lahlou L, Kharbach A, Baba M, Obtel M, Razine R Asian Pac J Cancer Prev. 2023; 24(8):2875-2884.
PMID: 37642077 PMC: 10685240. DOI: 10.31557/APJCP.2023.24.8.2875.
Utilization of opportunistic cervical cancer screening in Nigeria.
Habila M, Sagay E, Obeng-Kusi M, Ali M, Magaji F, Shambe I Cancer Causes Control. 2023; 35(1):9-20.
PMID: 37530986 DOI: 10.1007/s10552-023-01764-1.